Gasporox AB (publ) (STO:GPX)

Market Cap	56.12M -13.8%
Revenue (ttm)	38.32M +44.0%
Net Income	-3.06M
EPS	-0.33
Shares Out	9.35M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	969
Open	6.00
Previous Close	6.10
Day's Range	6.00 - 6.00
52-Week Range	5.85 - 9.40
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2026

About Gasporox AB

Gasporox AB (publ) engages in the development and commercialization of tunable diode laser absorption spectroscopy technology in Sweden. The company offers instruments, such as GPX1500 vial, GPX1500 film pharma, and GPX1500 film food; linearch machines; VialArch, BottleArch, AutoMAP pharma and food, and CellSpect sensors; and GPX HMI software. It also provides laboratory services, including alpha studies, multi-parameter analysis, batch check, stability studies, and customer defined studies; and IQ/OQ protocols, remote calibration services, tra...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 2005
• Employees: 22
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GPX

Financial Performance

In 2025, Gasporox AB's revenue was 31.57 million, a decrease of -7.42% compared to the previous year's 34.10 million. Losses were -7.71 million, 188.2% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 9, 2026

Data Sources Report a data error